Cortechs.ai | Poster – Performance Evaluation for Automated Lesion Segmentation Tool: LesionQuant

Poster – Performance Evaluation for Automated Lesion Segmentation Tool: LesionQuant

Cortechs.ai was pleased to present this poster at AAN in Boston – April 2017.

Quantitative measures such as lesion volume and distribution have significant value for clinicians evaluating disease progression. Clinical standards for lesion evaluation include visual inspection of MRI images, or expert manual segmentation of lesions. These subjective measurements are often vulnerable to inter- and intra-rater variability, resulting in low reproducibility.

Cortechs.ai’ LesionQuant is a fully-automated lesion segmentation tool for clinical use designed to provide accurate and reproducible lesion segmentations. This study objectively demonstrates that the accuracy of LesionQuant is comparable to expert manual segmentation of lesions and had high reproducibility, making it a useful tool in the quantitative analysis of the brain lesions.

For more information about LesionQuant or this poster, contact us. Click image below to view in pdf.

Cortechs.ai | Poster – Performance Evaluation for Automated Lesion Segmentation Tool: LesionQuant

More Resources

11/19/2025

Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

The companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems.

11/17/2025

Unlocking the Value of NeuroQuant Reports: Different Use Cases Across Clinical Practice

From neurodegeneration and demyelination to development, trauma, and seizures, NeuroQuant supports better decision‑making, communication, and patient care

11/17/2025

Case Study: Augmenting Prostate Imaging Programs with OnQ™ Prostate

Discover how Imaging Healthcare Specialists integrated OnQ™ Prostate to enhance lesion visibility, boost diagnostic confidence, and improve communication.

11/04/2025

NeuroQuant Dementia in Different Use Cases 

NeuroQuant transforms brain imaging into a measurable biomarker for neurodegeneration by combining volumetric data with clinical expertise.

10/29/2025

Enhancing Brain Tumor Treatment with RT STRUCT Images: The Promise of Automation

Automating the generation of RT STRUCT images with NeuroQuant Brain Tumor can streamline workflows and elevate the standard of care

10/15/2025

Sharper Screening, Smarter Biopsies: OnQ Prostate and the Next Step in Imaging

Read to learn how OnQ Prostate goes beyond existing solutions like DynaCAD and redefines biopsy precision
Scroll to Top